Intuitive Surgical defends its adverse event reports, which analysts at Citron Group call a ‘gross misuse of statistical data.’ The battle between surgical devices maker Intuitive Surgical (NSDQ:ISRG) and analysts at Citron Group continues to heat up, with harsh words from one and a stern defense from the other. Citron Group today issued an open letter to Intuitive Surgical, accusing the company of misusing FDA data to falsely paint a picture of declining adverse events associated with the da Vinci surgical robot.
Help employers find you! Check out all the jobs and post your resume.
